Neoplasms, Ovarian Completed Phase 2 Trials for Carboplatin (DB00958)

Also known as: Ovarian neoplasm / Ovarian Neoplasms / Neoplasms,Ovarian / Ovarian neoplasia / Ovarian tumor / Ovarian neoplasm NOS

IndicationStatusPhase
DBCOND0030336 (Neoplasms, Ovarian)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00316173Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian CancerTreatment
NCT00561795Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological TumorsTreatment
NCT01616303A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian CancerTreatment
NCT02107950Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian CarcinomaTreatment
NCT00112086OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206Treatment
NCT00610714AZD0530 Phase II Study in Patients With Advanced Ovarian CancerTreatment
NCT00780039A Study to Evaluate the Safety and Efficacy of Caelyx in Combination With Carboplatin in Patients With Ovarian Cancer Recurrent Within Six to Twelve Months After Initial Carboplatin and Paclitaxel Chemotherapy (P03625)Treatment
NCT00069901Phase II CT-2103/Carboplatin in Ovarian CancerTreatment